Caitlin Raymond/LinkedIn
Jan 13, 2026, 16:38
Caitlin Raymond: Understanding TAMOF as a TTP-Like Process
Caitlin Raymond, Assistant Professor of Pathology and Transfusion Medicine at the University of Wisconsin-Madison, shared on LinkedIn:
”New post, inspired by a case I saw on service: TTP’s Little-Known Cousin: Understanding TAMOF as a TTP-Like Process.
TAMOF is often mislabeled as DIC or dismissed as “just sepsis.”
But mechanistically, it behaves like a secondary thrombotic microangiopathy — driven by endothelial activation, ultra-large vWF, and insufficient ADAMTS13 in context.
The labs are subtle:
- Low platelets
- High LDH
- ± MAHA
- Relatively preserved coagulation studies
Seeing the pattern matters, because TAMOF may be treatable, including consideration of plasma exchange.”
Read the full post here.
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 03:49Domenico Simone Castiello: Rethinking Prolonged DAPT in Multivessel PCI – Insights from the DAPT-MVD Trial
-
Oct 20, 2026, 03:37Rucha Patil: Scaling POC Diagnostics for Haemophilia A and VWD Across India
-
Oct 20, 2026, 03:31Zena Vexler: Targeting Neutrophil Elastase and NETosis to Mitigate Infection-Triggered Childhood Stroke
-
Oct 20, 2026, 03:24Chaza Alaji: Diagnosing Protein C and Protein S Deficiency
-
Oct 20, 2026, 03:24Mou Nandi: How Maternal Health During Pregnancy May Shape Infant Development
-
Oct 20, 2026, 03:13Sumyea Kabir: Pre-Analytical Quality in Phlebotomy – Preventing In Vitro Hemolysis
-
Oct 20, 2026, 02:37M. Sekip Altunkan: Can Anticoagulation Be Safely Stopped After AF Ablation?
-
Oct 20, 2026, 02:26Ahmed Ammar: Managing VT Recurrence Post-Ablation
-
Oct 20, 2026, 01:43Oliver Weingärtner: Deprescribing of Lipid Lowering Drug after MI is Associated with Cardiovascular Events